-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NlfzjpxweTpor2/M8kLWBnpsd6qclW5EDlQSdZiN9nGekx/xg0v+YdgVM8pub2f5 ktPusI1yYFml84W7SsZuvA== 0000919015-02-000002.txt : 20020415 0000919015-02-000002.hdr.sgml : 20020415 ACCESSION NUMBER: 0000919015-02-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020408 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20020408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPHERE MEDICAL INC CENTRAL INDEX KEY: 0000919015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043216867 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23678 FILM NUMBER: 02604927 BUSINESS ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 BUSINESS PHONE: 7816817900 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 FORMER COMPANY: FORMER CONFORMED NAME: BIOSEPRA INC DATE OF NAME CHANGE: 19940215 8-K 1 body402.txt 1 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 -------------- FORM 8-K CURRENT REPORT -------------- PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 -------------------------------------- Date of Report (Date of earliest event reported): April 8, 2002 BIOSPHERE MEDICAL, INC. -------------------------------------------------------------- (Exact name of registrant as specified in its Charter) Delaware 0-23678 04-3216867 ------------------------- ------------ ----------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 1050 Hingham St. Rockland, Massachusetts 02370 ---------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (781) 681-7900 ---------------------------------------------------- (Former Name or Former Address if Changed Since Last Report) ================================================================================ 2 ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT On April 8, 2002, BioSphere Medical, Inc. (the Company) dismissed Arthur Andersen LLP (AA) as the Company's independent certifying accountants. The dismissal of AA was recommended by the Audit Committee of the Company's Board of Directors and approved by the Company's Board of Directors. The reports of AA on the Company's financial statements for fiscal years 2001 and 2000 contained no adverse opinions or disclaimers of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles. During fiscal years 2001 and 2000 and through April 8, 2002, there were no disagreements between the Company and AA on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of AA, would have caused AA to make reference to the subject matter of the disagreements in connection with its report on the Company's financial statements for such years. The Company has requested that AA furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not AA agrees with the above statements. A copy of such letter, dated April 8, 2002, is attached as Exhibit 16 to this Form 8-K. On April 8, 2002, the Company engaged Ernst & Young LLP (E&Y) as its independent certifying accountants for the year ending December 31, 2002. The appointment of E&Y was recommended by the Audit Committee of the Company's Board of Directors and approved by the Company's Board of Directors. 3 ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibits. Exhibit 16 Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated April 8, 2002. 4 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSPHERE MEDICAL, INC. (Registrant) Date: April 8, 2002 By: /s/ Robert M. Palladino -------------------------------- Vice President and Chief Financial Officer 5 INDEX TO EXHIBITS TO FORM 8-K EXHIBIT DESCRIPTION 16 Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated April 8, 2002 EX-16 3 exhib16.txt ARTHUR ANDERSEN LLP Office of the Chief Accountant Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 April 8, 2002 Dear Sir/Madam: We have read Item 4 included in the Form 8-K dated April 8, 2002 of BioSphere Medical, Inc. filed with the Securities and Exchange Commission and are in agreement with the statements contained therein as they pertain to Arthur Andersen LLP. Very truly yours, /s/ Arthur Andersen LLP - ----------------------- Arthur Andersen LLP -----END PRIVACY-ENHANCED MESSAGE-----